rolipram has been researched along with Osteosarcoma in 1 studies
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Narita, M | 1 |
| Murata, T | 1 |
| Shimizu, K | 1 |
| Sugiyama, T | 1 |
| Nakagawa, T | 1 |
| Manganiello, VC | 1 |
| Tagawa, T | 1 |
1 other study available for rolipram and Osteosarcoma
| Article | Year |
|---|---|
Phosphodiesterase 4 in osteoblastic osteosarcoma cells as a potential target for growth inhibition.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Antineoplastic Agents; Bone Neoplasms; Cell Division; Cell Line | 2003 |